{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:58:44Z","timestamp":1783767524741,"version":"3.55.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Urogenital tuberculosis is one of common sites of extrapulmonary tuberculosis. A 60-year-old man with an elevated prostate-specific antigen level underwent multiparametric MRI, which revealed abnormal signals in the prostate. However, the <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT results were unrevealing. Subsequent <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT imaging revealed intense radioactivity uptake in the prostate and mild radioactivity uptake in the left kidney, which was eventually proven due to tuberculosis.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005418","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T12:38:56Z","timestamp":1724848736000},"page":"98-100","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Increase 68Ga-FAPI Uptake in Urogenital Tuberculosis"],"prefix":"10.1097","volume":"50","author":[{"given":"Qiuming","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Division of Life Sciences and Medicine, Department of Nuclear Medicine, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Life Sciences and Medicine, Department of Nuclear Medicine, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Life Sciences and Medicine, Department of Nuclear Medicine, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ni","sequence":"additional","affiliation":[{"name":"Division of Life Sciences and Medicine, Department of Nuclear Medicine, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"bib1-20241203","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41585-019-0228-9","article-title":"Urogenital tuberculosis\u2014epidemiology, pathogenesis and clinical features","volume":"16","year":"2019","journal-title":"Nat Rev Urol"},{"key":"bib2-20241203","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/14787210.2021.1902305","article-title":"Current updates in diagnosis of male urogenital tuberculosis","volume":"19","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"bib3-20241203","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1148\/rg.2021200154","article-title":"Imaging manifestations of genitourinary tuberculosis","volume":"41","year":"2021","journal-title":"Radiographics"},{"key":"bib4-20241203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00345-019-02767-x","article-title":"Challenges in urogenital tuberculosis","volume":"38","year":"2020","journal-title":"World J Urol"},{"key":"bib5-20241203","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","year":"2023","journal-title":"Eur Urol"},{"key":"bib6-20241203","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000004430","article-title":"Comparison of 18F-PSMA-1007 PET\/CT with 68Ga-PSMA-11 PET\/CT for initial staging in intermediate- and high-risk prostate cancer","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib7-20241203","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1097\/RLU.0000000000004796","article-title":"Intravenous pyogenic granuloma in the inguinal canal mimicking lymph node metastasis on PSMA PET\/CT","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib8-20241203","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/RLU.0000000000003692","article-title":"68Ga-FAPI PET\/CT versus 18F-FDG PET\/CT for the evaluation of disease activity in takayasu arteritis","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib9-20241203","doi-asserted-by":"crossref","first-page":"e220749","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","year":"2023","journal-title":"Radiology"},{"key":"bib10-20241203","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/RLU.0000000000004767","article-title":"Displays of 18F-FAPI PET\/CT in myocarditis with variable symptom durations","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib11-20241203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.122.264544","article-title":"PET imaging of fibroblast activation protein in various types of cancer using 68Ga-FAP-2286: comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study","volume":"64","year":"2023","journal-title":"J Nucl Med"},{"key":"bib12-20241203","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/RLU.0000000000004498","article-title":"Increased FAPI activity in pulmonary tuberculosis","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib13-20241203","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1097\/RLU.0000000000004174","article-title":"Peritoneal tuberculosis mimicking peritoneal carcinomatosis on 68Ga-FAPI-04 and 18F-FDG PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib14-20241203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/RLU.0000000000003279","article-title":"68Ga-FAPI and 18F-FDG PET\/CT images in a patient with extrapulmonary tuberculosis mimicking malignant tumor","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib15-20241203","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/RLU.0000000000003990","article-title":"Bone tuberculous granulomatous inflammation mimicking malignancy on 68Ga-FAPI PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib16-20241203","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/RLU.0000000000004099","article-title":"68Ga-FAPI and 18F-FDG PET\/CT findings in a patient with pancreatic tuberculosis mimicking malignant tumor","volume":"47","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T23:00:18Z","timestamp":1733266818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005418","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,28]]}}}